Elder Pharmaceuticals announced impressive performance during the fourth quarter ended March 2006. Its net profit increased by 292 per cent to Rs 12.72 crore from Rs 3.24 crore in the corresponding period of last year. Its income from operations has gone up by 47.2 per cent to Rs 101.27 crore from Rs 68.79 crore.

The income for the year ended March 2006 went up to Rs 378.63 crore from Rs 304.86 crore in the previous year and its net profit went up sharply to Rs 37.74 crore from Rs 20.39 crore.

The company has presence in niche therapeutic segments like female healthcare, osteoporosis, pain management, nutraceuticals and vitamin supplements. Elder is a market leader in calcium supplement market through its brand Shelcal, which is ranked 23 rd amongst top 100 brands in India. It has also entered the dermatology and cardiology sectors.